Beijing Succeeder Technology Inc.

Shanghai Stock Exchange 688338.SS

Beijing Succeeder Technology Inc. Market Capitalization on January 14, 2025: USD 343.60 M

Beijing Succeeder Technology Inc. Market Capitalization is USD 343.60 M on January 14, 2025, a -26.56% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Beijing Succeeder Technology Inc. 52-week high Market Capitalization is USD 467.84 M on January 15, 2024, which is 36.16% above the current Market Capitalization.
Beijing Succeeder Technology Inc. 52-week low Market Capitalization is USD 292.82 M on February 05, 2024, which is -14.78% below the current Market Capitalization.
Beijing Succeeder Technology Inc. average Market Capitalization for the last 52 weeks is USD 357.98 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shanghai Stock Exchange: 688338.SS

Beijing Succeeder Technology Inc.

CEO	Mr. Hai Wang
IPO Date	Aug. 6, 2020
Location	China
Headquarters	Tower 1A
Employees	296
Sector	Health Care
Industries Biotechnology Chemicals & Advanced Materials Medical Instruments Pharmaceuticals

Description

Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. Its products include coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers, and platelet aggregation analyzers. The company was founded in 2003 and is headquartered in Beijing, China.

Key trends

Past 5 years